“Looking at the status of the pharmaceutical market, he says, “the environment includes generics product growth, and companies face compliance and adherence challenges that influence packaging.”
The Rockford, IL, firm specializes in clinical and commercial contract packaging, and is a wholly owned subsidiary of the Amerisource Bergen Corp. At Rockford, Anderson Packaging runs eight manufacturing facilities with more than one million square feet and 125 individual packaging lines, supplying pharmaceutical manufacturers of all sizes in the U.S. and in foreign countries.
Schroeder believes, “There's a significant problem facing the industry. The FDA is evolving, and the pharmaceutical industry needs to evolve along with it.”
Schroeder sees the pharmaceutical community putting greater focus on the financial bottom line. “There's a reconciling of assets and investments, with greater emphasis on return on investment. The traditional pharmaceutical approach is being replaced by companies looking to make better use of capital, improving their Overall Equipment Effectiveness [OEE], and moving from tactical, project-based outsourcing to a more strategic, partnership-based approach to outsourcing from product concept through commercialization, as a way to spread economic costs, and improve service and package performance.”
The Rockford, IL, firm specializes in clinical and commercial contract packaging, and is a wholly owned subsidiary of the Amerisource Bergen Corp. At Rockford, Anderson Packaging runs eight manufacturing facilities with more than one million square feet and 125 individual packaging lines, supplying pharmaceutical manufacturers of all sizes in the U.S. and in foreign countries.
Schroeder believes, “There's a significant problem facing the industry. The FDA is evolving, and the pharmaceutical industry needs to evolve along with it.”
Schroeder sees the pharmaceutical community putting greater focus on the financial bottom line. “There's a reconciling of assets and investments, with greater emphasis on return on investment. The traditional pharmaceutical approach is being replaced by companies looking to make better use of capital, improving their Overall Equipment Effectiveness [OEE], and moving from tactical, project-based outsourcing to a more strategic, partnership-based approach to outsourcing from product concept through commercialization, as a way to spread economic costs, and improve service and package performance.”
